- Home
- MTSI vs ASND Comparison
MTSI vs ASND Comparison
Compare MTSI & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTSI
- ASND
- Stock Information
- Founded
- MTSI 1950
- ASND 2006
- Country
- MTSI United States
- ASND Denmark
- Employees
- MTSI N/A
- ASND N/A
- Industry
- MTSI Semiconductors
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- MTSI Technology
- ASND Health Care
- Exchange
- MTSI Nasdaq
- ASND Nasdaq
- Market Cap
- MTSI 9.2B
- ASND 10.6B
- IPO Year
- MTSI 2012
- ASND 2015
- Fundamental
- Price
- MTSI $136.16
- ASND $175.45
- Analyst Decision
- MTSI Strong Buy
- ASND Strong Buy
- Analyst Count
- MTSI 9
- ASND 17
- Target Price
- MTSI $136.56
- ASND $222.18
- AVG Volume (30 Days)
- MTSI 702.9K
- ASND 428.9K
- Earning Date
- MTSI 07-31-2025
- ASND 09-02-2025
- Dividend Yield
- MTSI N/A
- ASND N/A
- EPS Growth
- MTSI N/A
- ASND N/A
- EPS
- MTSI N/A
- ASND N/A
- Revenue
- MTSI $845,205,000.00
- ASND $398,509,511.00
- Revenue This Year
- MTSI $33.87
- ASND $77.19
- Revenue Next Year
- MTSI $12.63
- ASND $75.84
- P/E Ratio
- MTSI N/A
- ASND N/A
- Revenue Growth
- MTSI 32.63
- ASND 12.06
- 52 Week Low
- MTSI $84.00
- ASND $111.09
- 52 Week High
- MTSI $152.50
- ASND $183.00
- Technical
- Relative Strength Index (RSI)
- MTSI 53.66
- ASND 54.14
- Support Level
- MTSI $135.16
- ASND $168.01
- Resistance Level
- MTSI $141.75
- ASND $180.00
- Average True Range (ATR)
- MTSI 3.66
- ASND 6.12
- MACD
- MTSI -1.02
- ASND -0.28
- Stochastic Oscillator
- MTSI 24.58
- ASND 59.33
About MTSI MACOM Technology Solutions Holdings Inc.
MACOM Technology Solutions Holdings Inc is a provider of analog, digital, and mixed-signal semiconductor solutions to original equipment manufacturers and distributors. These solutions are found in systems for industrial, medical, scientific, and test and measurement markets. The firm's portfolio of products includes integrated circuits, multichip modules, power pallets and transistors, diodes, amplifiers, switches and switch limiters, passive and active components, and complete subsystems. Roughly a third of the firm's revenue is generated in the United States, with the rest coming from China, Japan, Singapore, South Korea, and other countries across the world.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.